BiotechTube
Home/Origenis/Michael Almstetter
MA

Michael Almstetter

Co-Founder

Origenis

Therapeutic Areas

NeurodegenerationOncologyOphthalmology

Origenis Pipeline

DrugIndicationPhase
Neurodegeneration PipelineNeurodegenerative DiseasesPreclinical
Brain Cancer PipelineBrain CancersPreclinical
Ophtha PipelineOphthalmic DiseasesPreclinical

Leadership Team at Origenis

DM
Dr. Michael Thormann
Co-Founder
DA
Dr. Andreas Treml
Co-Founder
View full Origenis profile